Market Cap 549.03M
Revenue (ttm) 0.00
Net Income (ttm) -46.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,361,000
Avg Vol 2,425,084
Day's Range N/A - N/A
Shares Out 69.23M
Stochastic %K 56%
Beta 0.49
Analysts Sell
Price Target $8.80

Latest News on RGLS

Novartis to Acquire Regulus in $1.7 Billion Deal

Apr 30, 2025, 7:50 AM EDT - 5 weeks ago

Novartis to Acquire Regulus in $1.7 Billion Deal

NVS


Novartis to buy Regulus Therapeutics for up to $1.7 billion

Apr 30, 2025, 7:25 AM EDT - 5 weeks ago

Novartis to buy Regulus Therapeutics for up to $1.7 billion

NVS